Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Cancer Experts, Patients, and Families Meet for Local Blood Cancer Conference
  • USA - English


News provided by

MedEd Consulting, Inc.

Apr 16, 2018, 03:00 ET

Share this article

Share toX

Share this article

Share toX

5th Annual CE-accredited, 1-day Educational Conference
5th Annual CE-accredited, 1-day Educational Conference

ALBANY, N.Y. (PRWEB) April 16, 2018 -- Spring to Life Conference on Hematologic Malignancies™: Conference on Indolent Lymphoid Malignancies is an accredited, educational program developed by New York Oncology Hematology (NYOH), in collaboration with the Center for Emergency Medical Education (CEME), the Leukemia & Lymphoma Society, and a panel of expert faculty from the academic, research, and community practice settings.

Local cancer organizations have come together to help healthcare providers, patients, and families dealing with indolent lymphoid malignancies. The fifth annual Spring to Life Conference on Hematologic Malignancies, sponsored by New York Oncology Hematology, will be held at the Albany Marriott Hotel, Albany, NY on Saturday, May 19, 2018, from 7:30 am – 3:45 pm.

This one-day CME-certified conference will bring together healthcare professionals and members of the community—including patients, survivors, family members, and caregivers—to gain an up-to-date understanding of blood cancers, including the state-of-the-art science behind treatment, clinical management, ongoing translational research, and emerging therapies.

“Our Spring to Life conference each year highlights a different focus in the broad spectrum of hematologic malignancies or blood cancers and brings regional expertise to our community,” explains Ira Zackon, MD, New York Oncology Hematology and Conference Chair and Moderator. “Continued education at the local community level is critical to maintaining the highest quality and leading edge of health care. Each year we select a different group of blood cancers on which to focus, so that we are continually updating our knowledge and care. Our afternoon session focuses on an aspect of living with cancer and this year we are engaging around managing transitions in our lives through the course of disease.”

The 2018 conference will focus on indolent lymphoid malignancies with experts from New York Oncology Hematology, PC (NYOH) Albany Medical College, the Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, and University of Rochester Medical Center.

“At Leukemia & Lymphoma Society (LLS) our mission is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families," said Sadie Szrama, Leukemia & Lymphoma Society Manager, Patient Access Volunteer Development. “The Spring To Life Conference on Hematologic Malignancies provides a wonderful opportunity for patients and caregivers to come together, share their experiences, and work together to improve care.”

The event is divided into two, half-day sessions:

• Professional program (7:30 AM ‒ 1:15 PM): The morning program will detail standards of care and current evidence-based and emerging therapeutics, including efficacy, safety, and tolerability, in order to inform a clinical audience on the more common indolent lymphomas and chronic lymphocytic leukemia. These sessions are designed to meet the educational needs of primary care practitioners, hematologists, oncologists, pediatricians, allied health professionals (including nurses, pharmacists, and social workers), and basic scientists.
• Patient-centered program: (1:30 PM ‒ 3:45 PM): The theme of the afternoon program is Finding Hope in Times of Transition. This session is designed to benefit patients, as well as their families, companions, and caregivers. Patients and their loved ones will join health care experts, community oncologist/hematologists, and social workers to share stories and improve understanding in a supportive environment.

The symposium is hosted by New York Oncology Hematology, the region’s largest provider of community cancer care. It is accredited by Center for Emergency Medical Education (CEME) for 3.75 AMA PRA Category 1 Credits ™. Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 3.75 continuing education contact hours through the California Board of Registered Nursing.

Conference attendees will enjoy complimentary breakfast, light lunch, and snacks, as well as opportunities to view exhibitor displays.
There is no fee for this educational activity.

For more information or to register, visit: https://www.ceme.org/spring-2-life-conference for the morning healthcare professional program, or http://spring2liferegistration.org/ for the afternoon patient-centered program.

***
About New York Oncology Hematology
New York Oncology Hematology (NYOH) is the region’s leading provider of community-based cancer care and services. With seven convenient locations, a team of 36 physicians, and more than 300 oncology professionals, NYOH has been delivering world-class cancer care to the Capital Region and surrounding communities for more than 30 years. Through its affiliation with The US Oncology Network, one of the nation’s largest cancer treatment and research networks, NYOH offers the latest breakthroughs, treatments, and technologies – right here at home.

About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society ® (LLS) is the world’s largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services. Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. The Upstate NY/VT Chapter is located in Albany, NY.

ACCREDITATION INFORMATION
ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Center for Emergency Medical Education and MedEd Consulting.

AMA Credit Designation Statement
The Center for Emergency Medical Education (CEME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Center for Emergency Medical Education (CEME) designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Accreditation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 3.75 continuing education contact hours through the California Board of Registered Nursing.

Donna Falco, MedEd Consulting, Inc., https://ceme.org/content/heart-course-1#group-tabs-node-course-default1, +1 (866) 599-7299 Ext: 5, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.